Literature DB >> 29752989

A novel pathogenic variant in the MARVELD2 gene causes autosomal recessive non-syndromic hearing loss in an Iranian family.

Afsaneh Taghipour-Sheshdeh1, Fatemeh Nemati-Zargaran1, Narges Zarepour1, Parisa Tahmasebi2, Nader Saki3, Mohammad Amin Tabatabaiefar4, Javad Mohammadi-Asl5, Morteza Hashemzadeh-Chaleshtori6.   

Abstract

BACKGROUND AND AIMS: Hearing loss (HL) is the most common sensorineural disorder and one of the most common human defects. HL can be classified according to main criteria, including: the site (conductive, sensorineural and mixed), onset (pre-lingual and post-lingual), accompanying signs and symptoms (syndromic and non-syndromic), severity (mild, moderate, severe and profound) and mode of inheritance (Autosomal recessive, autosomal dominant, X-linked and mitochondrial). Autosomal recessive non-syndromic HL (ARNSHL) forms constitute a major share of the HL cases. In the present study, next-generation sequencing (NGS) was applied to investigate the underlying etiology of HL in a multiplex ARNSHL family from Khuzestan province, southwest Iran.
METHODS: In this descriptive study, 20 multiplex ARNSHL families from Khuzestan province, southwest of Iran were recruited. After DNA extraction, genetic linkage analysis (GLA) was applied to screen for a panel of more prevalent loci. One family, which was not linked to these loci, was subjected to Otogenetics deafness Next Generation Sequencing (NGS) panel.
RESULTS: NGS results showed a novel deletion-insertion variant (c.1555delinsAA) in the MARVELD2 gene. The variant which is a frameshift in the seventh exon of the MARVELD2 gene fulfills the criteria of being categorized as pathogenic according to the American College of Medical Genetics and Genomics (ACMG) guideline.
CONCLUSION: NGS is very promising to identify the molecular etiology of highly heterogeneous diseases such as HL. MARVELD2 might be important in the etiology of HL in this region of Iran.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARNSHL; DFNB loci; Genetic linkage analysis; NGS

Year:  2018        PMID: 29752989     DOI: 10.1016/j.ygeno.2018.05.008

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  1 in total

1.  Identification of novel variants in MYO15A, OTOF, and RDX with hearing loss by next-generation sequencing.

Authors:  Xuejing Bai; Shiyan Nian; Lei Feng; Qingrong Ruan; Xuan Luo; Mengna Wu; Zefeng Yan
Journal:  Mol Genet Genomic Med       Date:  2019-06-28       Impact factor: 2.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.